So far, immune cells that have been engineered to kill cancers, known as CAR T-cells, haven’t worked well against solid ...

Advances in cancer immunotherapy from immune checkpoint modulation to adoptive cell transfer of tumour-infiltrating ...

Nkarta, Inc. (($NKTX)) announced an update on their ongoing clinical study. Study Overview: Nkarta, Inc. is conducting a Phase 1 study titled ‘A ...

Liberate Bio’s CAR-M cell therapy almost completely depleted B-cells in a nonhuman primate study, the company said.

A newly developed antibody which restricts the growth of treatment-resistant breast cancers offers new hope for patients.

Long-term follow-up shows 95% success rate, no serious complications in largest ADA-SCID gene therapy study to date ...

The first patient has been dosed in a Phase 1 trial testing the experimental CAR T-cell therapy obecabtagene autoleucel for progressive MS.

By analyzing the tumor environment of diffuse large B-cell lymphoma (DLBCL), researchers from The University of Texas MD ...

Fibrosis occurs when inflammation activates immune cells and fibroblasts to release collagen and cytokines that remodel and ...

MIT and Harvard scientists have designed an advanced type of immune cell called a CAR-NK cell that can destroy cancer while ...

Researchers at UCLA have developed a powerful new weapon in the battle against kidney cancer. Instead of relying on treatments tailored to each patient, this innovation uses specially engineered ...

The post This Covid-19 Vaccine Could Unlock the Next Revolution in Cancer Treatment appeared first on Katie Couric Media. If ...